Oct. 31 (Reuters) – Progressive US Senator Bernie Sanders said on Sunday he was still working to include a provision to cut prescription drug prices in the social spending bill pending in Congress American before a vote in the House of Representatives.
President Joe Biden suffered a setback Thursday as the House scrapped plans to vote on an infrastructure bill before he left Europe for an international summit with other world leaders, with Progressive Democrats seeking more time to consider its call for a separate $ 1.75 trillion. plan to address climate action, preschool and other social initiatives. Read more
A proposal that would allow the US government’s Medicare health plan for the elderly to negotiate the prices of prescription drugs to make them cheaper was not included in the social spending bill. Read more
âI spent all day yesterday on the phoneâ¦ We are continuing this effort (to include the prescription drug pricing provision in the bill),â Sanders told CNN in an interview on Sunday.
“It is scandalous that we continue to pay the highest prices in the world for prescription drugs,” added Sanders, who has championed this cause for years.
Biden had sought to unite his fellow Democrats behind the climate and social spending plan with personal appeals on Thursday, and pushed for a vote Thursday on the $ 1,000 billion infrastructure bill, another mainstay of its national program.
He hoped a framework on the larger measure would convince progressive House Democrats to back the infrastructure bill, but their insistence that the two act together led House leaders to drop a planned vote.
The plan also didn’t include paid family leave or billionaire tax, with some constituencies angered by the Biden administration’s lack of key commitments in the bill. Read more
The lack of paid family leave, Democrats noted, has left the United States as the only wealthy country and one of the few countries in the world that does not pay women during maternity leave.
Report by Kanishka Singh in Bengaluru; Editing by Bill Berkrot
Our Standards: Thomson Reuters Trust Principles.